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Abstract:  
Background: The Human Papillomavirus (HPV) is strongly associated with cervical and other cancers.  In 
women, cervical cancer is the third most common cancer.  HPV infection can be largely prevented through 
vaccination of (adolescent) girls. At the same time, Nepal is a low-income country experiencing a cultural 
change in attitudes towards sex and sexual behaviour. However, in the adolescent population knowledge about 
HPV, factors associated with an increased risk of HPV and the existence of the vaccination is often low. 
Materials and Methods: This was a cross-sectional study with female students enrolled in health and non-
health science courses in Pokhara, Nepal. The questionnaire included demographic details, knowledge and 
attitude questions related to HPV, associated risk behaviour and its vaccination.   Descriptive statistics, 
including Chi-Square test, were used to identify statistically significant relationships.  Ethical approval was 
granted by the relevant authority in Nepal. 
Results: Hindu religion (75.0 %; 95% CI: 70.9, 78.6) and Newari caste (75.5%; CI: 61.1, 86.7) were more 
aware about HPV, HPV vaccination. Hindus religion (55.6%; 95% CI: 51.2, 60.0) and Dalit caste (61.6%, 
95% CI: 53.3, 69.4) more willing to be vaccinated than other religions and other castes, respectively.  Not 
unsurprisingly, students on health-related courses had a greater awareness of HPV, HPV vaccination and were 
more willing to be vaccinated than students on other courses.  Similar patterns of association arose for 
knowledge related to those sexually active at an early age; HPV risk and multiple sex partners; and fact that 
condoms cannot fully prevent the transmission of HPV. 
Conclusion: Knowledge about the link between HPV and (a) early sexual initiation, (b) having multiple sexual 
partners, and (c) the limited protection of condoms and other birth control measures was poor in our study 
compared to similar research conducted in other parts of the world.  One key implication is the need for 
education campaigns in Nepal to educate young women and their parents about HPV, its risk factors and the 
benefits of vaccination. 
Keyword: Human papillomavirus; HPV vaccination; HPV awareness; cervical cancer; Youth.  
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Introduction 
Genital Human papillomavirus (HPV) infection is the most 
common sexually transmitted infection (STI) throughout the 
world which causes 99.7% of cervical cancer, 90% of anal 
cancer, 40% of vulvar, vaginal, or penile cancers, and 12% of 
oral and pharyngeal cancers [1, 2]. It is commonly seen in 
women who had a higher number of sexual partners or had sex 
with men, who had sex with multiple partners [3-5]. It is 
estimated that more than 80% of sexually active women will 
have genital HPV by the time they reach the age of 50 years 
[1]. Although most infections are transient and asymptomatic, 
persistent infection with a high-risk type of HPV can lead to 
precancerous lesion and progress to cancer [6, 7]. The most 
common cancer in women is cervical cancer which can be 
lethal once it reaches the invasive stages. However, out of all 
the female genital tract cancers, it is the only preventable 
cancer if detected early enough [1, 8]. A data-based study in 
2008 on cervical cancer has indicated that there were 275,000 
deaths out of an estimated 530,000 cervical cancer cases 
worldwide. 85% of the global burden due to cervical cancer 
falls to Low-Income Countries with overall 52% mortality 
incidence ratio and cervical cancer is responsible for about 
88% of death which occur in developing countries. This 
suggests a lack of effective public health control measures and 
lack of infrastructure in many developing countries [5, 9]. In a 
low-income country like Nepal, where traditional sexual 
norms are changing, more young people are at risk of 
developing STIs including HPV than in the past. The risk of 
developing HPV-related disease has become endemic in 
regions that support child marriages, polygamy, high parity, 
and long-term oral contraceptive use [5-7]. Cervical cancer is 
one of the most commonly reported cancer among women in 
Nepal and has higher incidence rate (14.9) than other HPV-
related cancers [10-12]. The age-standardized rate (ASR) of 
cervical cancer for women in Nepal was found to be 19.0 for 
the year 2014. Every year 1367 die out of 2332 women who 
are diagnosed with cervical cancer in Nepal. [12]. Fortunately, 
there is an important secondary preventive measure for 
cervical cancer such as effective Population-based screening, 
Pap smear testing, HPV DNA testing, visual inspection with 
acetic acid and HPV vaccine, that leads to a high cure rate 
among cervical cancer patients [1, 5, 13]. 
Vaccination will be most effective if it is given before the 
onset of the sexual activity and will be useful who are already 
sexually active [14]. A 9-valent-HPV Vaccine, a recent 
investigation by Joura et al, can prevent infection and disease 
related to HPV (HPV Types; 6, 11, 16, 18, 31, 33, 45, 52, and 
58) [15]. Singh et al. had conducted an HPV vaccination 
programme in school girls in Nepal with help of Australian 
Cervical Cancer Foundation and suggested that high cost and 
low public awareness were the key barriers to successful 
implementation of a vaccination programme in Nepal [16, 13]. 
Though Nepal is one of the “countries eligible for GAVI 
Alliance support” for vaccination [17], since the incidence rate 
of cervical cancer is high, vaccination programme will require 
major donor funding until mature, affordable prices are 
achieved [2]. Apart from high cost, religious beliefs, practicing 
cast system, parent’s acceptance, lack of permission from 
husband and lack of public awareness also influence on 
making decision for vaccination and prevents women from 
participating in screening programme. Though vaccination is a 
most successful public health approach in protecting and 
controlling HPV infection [14], for successful implementation 
of the vaccine, it is necessary to bring awareness regarding 
HPV, cervical cancer, and the benefits of HPV vaccination 
among young women. Because it will be difficult for women 
to undergo screening test and getting vaccinated in the absence 
of symptoms [10]. Public health programmes may help to 
overcome such difficulties but such programmes are only 
going to succeed if the level of HPV awareness among women 
is high. Since HPV poses a greater threat to women’s health 
than men’s, research has focused primarily on women’s 
awareness and knowledge of HPV. Various studies have 
evaluated women’s awareness and knowledge levels of 
cervical cancer and HPV [18-23]. Although a number of 
studies worldwide found women’s knowledge to be poor, there 
appears to be strong support for HPV vaccination [1, 24-26].  
Therefore, establishing the knowledge and awareness about 
HPV and its vaccination in women and identifying sub-groups 
of women in the target age group for HPV vaccination, who 
are having lower levels of knowledge, is crucial before any 
screening test and vaccination programme. The objective of 
our study was to establish the knowledge of HPV and its 
vaccination among female students studying in Pokhara, 
Nepal. 
Methodology 
Study design and the participants: 
This cross-sectional study was carried out during July-
December, 2013 in a community setting with female 
undergraduate students of Pokhara sub metropolitan city, 
Western Nepal. Pokhara has 28 Wards, 82870 House Hold, 
and population as 152651 Male, 161190 Female, 313841 
Total. A cross-sectional survey can provide key information 
on associations and risk factors [27].  
Data collection 
The questionnaires were administered in face-to-face 
interviews by trained researchers.  Data were collected from 
female students who are educated in English in their colleges 
in Pokhara, Nepal.  This study used a convenience sample. 
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Questionnaire 
An extensive review of the literature, combined with 
exploratory research and qualitative piloting [28] contributed 
to the development and refinement of a structured 
questionnaire in English. The questionnaire was validated 
using reliability analysis resulting in a high Cronbach’s alpha 
score of 0.801. Therefore, the questionnaire was not changed 
after piloting. Those who completed the pilot were also 
included in the study. We used the information from the pilot 
study for calculating the required sample size. The 
questionnaire included questions on HPV awareness as well as 
knowledge of risk factors associated with HPV transmission.  
The latter included questions such as whether the sexual 
activity at an early age can cause HPV-related cervix cancer 
(risk), sexual contact with multiple partners (transmission), 
and whether condoms offered protection (measures to control). 
The items were not grouped according to the type of question 
so that the individual influence of each variable could be 
examined. 
Inclusion criteria: 
All the female students who are educated in English in their 
colleges were included in the study.  
Exclusion criteria:  
Those who refused to consent were excluded from the study. 
Sample size calculation:  
A total of 700 female under graduate students were invited to 
the questionnaire study.  The sample size calculation 
suggested that for a 95% confidence interval and significance 
level α = 5%, P = 0.525, Q = 0.475, allowable error = 8%, 
whereby P = awareness of HPV in Nepal [29, 30], the required 
sample size was 543. 
Outcome Variable:  
The respondents’ answers to the questionnaire were coded in a 
yes/no response format. Dependent variables were awareness 
about HPV infection, HPV vaccination, HPV-related cervix 
cancer. 
Explanatory variables: 
The demographic factors such as age, religion, and ethnicity 
were taken as the independent variables. 
Ethical committee approval: 
Ethics approval was obtained prior from the Institutional 
Research and Ethics Committee of Manipal College of 
Medical Sciences, Pokhara, Nepal (affiliated to Kathmandu 
University) which is authorized by Nepal Health Research 
Council (NHRC). Written consent was obtained from the 
participants.  The researchers described the purpose and 
process of study to the respondents and emphasized 
confidentiality and anonymity.  It was made very clear to the 
participants that they had the freedom of not participating in 
the study.  All the concerns raised by the participants were 
addressed. Our research was conducted in accordance with the 
Declaration of Helsinki [32]. 
Data management and statistical analysis: 
The data collected were analyzed using EPI-Info 3.5.1 
Windows Version. Descriptive statistics, testing of hypothesis 
with Chi-Square test for finding the relationship between two 
variables and 95% confidence intervals (95% CI) were used to 
interpret the data [31]. 
Results 
Sample Characteristics 
The interview was conducted in 700 female students and 685 
students were completed the interview. Totally 15 students 
were dropped out from the study due to poor response. Since 
overall response rate was high (97.86%) and the numbers 
students (n=685) after dropouts (n=15) were not less than the 
calculated sample size (n=578), removing 15 students from the 
study did not have any impact on our result. The average age 
of the students was 18.5 (Mean± SD; 18.56±0.831) with the 
range of 18 to 21 years of age. Most of the students were 
belong to Hindu religion [507 (74%)] and Chettri caste [180 
(26.1%)]. The number of non-health science students [362 
(52.8%)] were slightly more than health science students [323 
(47.2%)]. All other socio-demographic details of the students 
were shown in Table 1. On considering knowledge of the 
students about HPV, HPV vaccine, and sexual behavior, most 
of the students (71.7 %) knew about HPV, but only 51.8% of 
the students knew about the HPV vaccine and they were 
willing to be vaccinated. Over one-third of the students knew 
risk (37.5%), transmission (44.1%) and measures to control of 
HPV (40.4%).  
 
Knowledge and attitudes towards HPV by Religion, Caste, 
and Education  
Table 2 shows that more Hindu students were aware of HPV 
(75.0%; 95% CI: 70.9, 78.6), HPV vaccination and also 
willing to be vaccinated (55.6%; 95% CI: 51.2, 60.0) than 
students of other religions. A significant number of Muslim 
students (70.0%; 95% CI: 50.6, 85.3) were not willing to be 
vaccinated thought they were aware of HPV. On considering 
the knowledge of students related to risk, transmission, and 
measures to control HPV, many students had selected the 
option “No” in the questionnaire. Muslim students had less 
knowledge related to risk (73.3%; 95% CI: 54.1, 87.7), 
transmission (80.0%; 95% CI: 61.4, 92.3) and measures to 
control (73.3%; 95% CI: 54.1, 87.7) HPV. 
Table 3 suggests that the majority of students (P=0.01) of 
different castes were aware of HPV, but only Brahmin (52%; 
95% CI: 43.3, 61.5), Newari (61.2%; 95% CI: 46.2, 74.8), and 
Dalit (61.6%; 95% CI: 53.3, 69.4) castes students were 
showed their willingness for vaccination against HPV. 
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Whereas only 50% of Chettri caste students were willing to be 
vaccinated. On comparing the knowledge related to risk, 
transmission, and measures to control HPV among different 
caste students, most of them did not have the knowledge about 
it. But slightly more number of students in Newari (53.1%; 
95% CI: 38.3, 67.5) and Dalit (51.7%; 95% CI: 43.4, 59.9) 
castes were known about the transmission of HPV through 
multiple sex partners.  
On comparing knowledge and attitude towards the HPV 
between health science and non- health science students, a 
significant number of health science students (98.8%; 95% CI: 
96.6, 99.6; p<0.001] were aware of HPV, its vaccination and 
willing to be vaccinated. Almost identical patterns occurred 
for knowledge related to risk, transmission, and measures to 
control HPV (p<0.001) which is shown in Table 4. 
  
 
 
Table 1: Socio-demographic characteristics of the respondents 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables n (%) 
Religion  
Hindu 507 (74.0) 
Muslim 30 (4.4) 
Christian 32 (4.7) 
Buddhist 116 (16.9) 
Caste  
Brahmin 124 (18.1) 
Chettri 180 (26.3) 
Newar 49 (7.2) 
Gurung 77 (11.2) 
Dalit 151 (22.0) 
Magar, Pun, Lama 39 (5.7) 
Other 65 (9.5) 
Education  
Non-Medical 362 (52.8) 
Medical/ Health Science 323 (47.2) 
  
Total 685 
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Table 2:  Knowledge and attitudes towards HPV by religion 
 
 
 
 
 
 Religion 
n [(%(95%CI)] 
Questionnaire Items Hindu Muslim Christian Buddhist p 
value 
Do you know about HPV 
vaccine and are you willing to 
be vaccinated? 
No 225[44.4(40.0, 48.8)] 21[70.0(50.6, 85.3)] 17[53.1(34.7, 70.9)] 67[57.8(48.2, 66.9)] 0.004† 
Yes 282[55.6(51.2, 60.0)]  9[30.0(14.7, 49.4)] 15[46.9(29.1, 65.3)] 49[42.2(33.1, 51.8] 
Are you aware of human 
papillomavirus (HPV) and 
pap smear test?  
No 127[25.0(21.4, 29.1)] 12[40.0(22.7, 59.4)] 10[31.3(16.1, 50.0)] 45[38.3(29.9, 48.3)] 0.001† 
Yes 380 [75.0(70.9,78.6)] 18[60.0(40.6, 77.3)] 22[68.8(50.0, 83.9)] 71[61.2(51.7, 70.1)] 
Do you know being sexually 
active at an early age (before 
age 16) increases the chance 
of HPV-related cervical 
cancer?  
No 310[61.1(56.7, 65.4)] 22[73.3(54.1, 87.7)] 21[65.6(46.8, 81.4)] 75[64.7(55.2, 73.3)] 0.520* 
Yes 197[38.9(34.6, 43.3)]  8[26.7(12.3, 45.9)] 11[34.4(18.6, 53.2)] 41[35.3(26.7, 44.8)] 
Do you know HPV can be 
transmitted through multiple 
sex partners?  
No 266[52.5(48.0, 56.9)] 24[80.0(61.4, 92.3)] 19[59.4(40.6, 76.3)] 74[63.8 (54.4,72.5)] 0.006† 
Yes 241[47.5(43.1, 52.0)] 6[20.0(7.7, 38.6)] 13[40.6(23.7, 59.4)] 42[36.2(27.5, 45.6)] 
Do you know using of 
condom/other birth control 
measures cannot prevent fully 
the transmission of HPV?   
No 292[57.6(53.2, 61.9)] 22[73.3(54.1, 87.7)] 19[59.4(40.6, 76.3)] 75[64.7(55.2, 73.3)] 0.219* 
Yes 215[42.4(38.1, 46.8)]  8[26.7(12.3, 45.9)] 13[40.69(23.7,59.4)] 41[35.3 (26.7,44.8)] 
* Not Statistically Significant [p-value >0.05] 
† Statistically Significant [p-value <0.05] 
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Table 3   Knowledge and attitudes towards HPV by caste 
 
 
 
 
 
 
 
 
 
 
 
 
Caste 
n [(%(95%CI)] 
Questionnaire Items Brahmin Chettri Newar Gurung Dalit Magar, Pun, 
Lama 
Other p 
value 
Do you know about 
HPV vaccine and are 
you willing to be 
vaccinated?  
No 59 [47.6(38.5, 
56.7)] 
90[50.0(42.
5, 57.5)] 
19[38.8(25.
2, 53.8)] 
42[54.5(4
2.8,65.9)] 
58[38.4(30.6, 
46.7)] 
25[64.1(47.2, 
78.8)] 
37[56.9(44.0, 
69.2)] 
0.021† 
Yes 65[52(43.3,   
61.5)] 
90[50(42.5, 
57.5)] 
30[61.2(46.
2, 74.8)] 
35[45.5(4
2.8,65.9)] 
93[61.6(53.3, 
69.4)] 
14[35.9(21.2, 
52.8)] 
28[43.1(30.8, 
56.0)] 
Are you aware of 
human papillomavirus 
(HPV) and pap smear 
test?  
No 33[26.6(19.1, 
35.3)] 
55[30.6(23.
9, 37.8)] 
12[24.5(13.
3, 38.9)] 
29[37.7(2
6.9,49.4)] 
27[17.9(12.1, 
22.7)] 
16[41.0(25.6, 
57.9)] 
22[33.8(22.6, 
46.6)] 
0.011† 
Yes 91[73.4(64.7, 
80.9)] 
125[69.4(6
2.2, 76.1)] 
37[75.5(61.
1, 86.7)] 
48[62.3(5
0.6,73.1)] 
124[82.1(75.
1, 87.5)] 
23[59.0(42.1, 
74.4)] 
43[66.2 (53.4, 
77.4)] 
Do you know being 
sexually active at an 
early age (before age 
16) increases the chance 
of HPV-related cervical 
cancer?  
No 75[60.5(51.3, 
69.1)] 
108[60.0(5
2.4, 67.2)] 
28[57.1(42.
2, 71.2)] 
49[63.6(5
1.9,74.3)] 
95[62.9(54.7, 
70.6)] 
26[66.7(49.8, 
80.9)] 
47[72.3(72.3, 
82.7)] 
0.636* 
Yes 49[39.5(30.9, 
48.7)] 
72[40.0(32.
8, 47.6)] 
21[42.9(28.
8, 57.8)] 
28[36.4(2
5.7,48.1)] 
56[37.1 
(29.4, 45.3)] 
13[33.3(19.1, 
50.2)] 
18[27.7(17.3, 
40.2)] 
Do you know HPV can 
be transmitted through 
multiple sex partners?  
No 71[57.3(48.1, 
66.1)] 
97[53.9(46.
3, 61.3)] 
23[46.9(32.
5, 61.7)] 
45[58.4(4
6.6,69.6)] 
73[48.3(40.1, 
56.6)] 
29[74.4(57.9, 
87.0)] 
45[69.2(56.6, 
80.1)] 
0.015† 
Yes 53[42.7(33.9, 
51.9)] 
83[46.1(38.
7, 53.7)] 
26[53.1(38.
3, 67.5)] 
32[41.6(3
0.4,53.4)] 
78[51.7 
(43.4, 59.9)] 
10[25.6(13.0, 
42.1)] 
20[30.8 (19.9, 
43.4)] 
Do you know using of 
condom/other birth 
control measures cannot 
prevent fully the 
transmission of HPV?   
No 77[62.1(52.9, 
70.7)] 
105[58.3(5
0.8, 65.6)] 
27[55.1(40.
2, 69.3)] 
46[59.7(4
7.9,70.8)] 
81[53.6(45.4, 
61.8)] 
29[74.4(57.9, 
87.0)] 
43[66.2(53.4, 
77.4)] 
0.256* 
Yes 47[37.9(29.3, 
47.1)] 
75[41.7(34.
4, 49.2)] 
22[44.9(30.
7, 59.8)] 
31[40.3(2
9.2,52.1)] 
70[46.4(38.2, 
54.6)] 
10[25.6(13.0, 
42.1)] 
22[33.8(22.6, 
46.6)] 
* Not Statistically Significant [p-value >0.05] 
† Statistically Significant [p-value <0.05] 
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Table 4:  Knowledge and attitudes towards HPV by type of education 
 
 
Education (type) 
n [(%(95%CI)] 
Questionnaire Items Non-Medical / 
Health 
Medical/ Health 
Science 
p 
Value 
Do you know about HPV vaccine and are 
you willing to be vaccinated? 
No 326[90.1(86.5, 92.9)]  4[1.2(0.4, 3.4)] p<0.0001† 
Yes 36[9.9(7.2, 13.6)] 319[98.8(96.6, 99.6)] 
Are you aware of human papillomavirus 
(HPV) and pap smear test?  
No 190[52.5(47.2, 57.7)]  4[1.2(0.4, 3.4)] p<0.0001† 
Yes 172[47.5(42.3,52.8)] 319[98.8(96.6, 99.6)] 
Do you know being sexually active at an 
early age (before age 16) increases the 
chance of HPV-related cervical cancer?  
No 280[77.3(72.7, 81.6)] 148[45.8(40.3, 51.4)] P<0.0001† 
Yes 82[22.7(18.5, 27.4)] 175[54.2(48.6, 59.7)] 
Do you know HPV can be transmitted 
through multiple sex partners?  
No 287[79.3(74.7, 83.3)] 96[29.7(24.9, 35.1)] p<0.0001† 
Yes 75[20.7(16.7, 25.3)] 227[70.3(65.0, 75.2)] 
Do you know using condom/other birth 
control measures cannot prevent fully 
transmission of HPV?   
No 285[78.7(74.1, 82.8)] 123[38.1(32.8, 43.6)] p<0.0001† 
Yes 77[21.3[17.2, 25.9)] 200[61.9(56.4, 67.2)] 
 
† Statistically Significant [p-Value <0.05] 
 
 
Discussion: 
Education  
Women’s participation in all sectors of development has 
increased tremendously worldwide. Although Nepal has the 
most dismal female literacy rate in the SAARC (South Asia 
association for Regional Cooperation) [33], the percentage of 
school going children is increasing trend in recent years [34]. 
The increasing formal education rates of adolescent girls have 
a positive effect on their overall understanding of health and 
disease. The widespread awareness programme nowadays has 
certainly brought significant changes in adolescent girl’s 
attitude towards diseases like HPV [35-41]. Effect of such 
awareness programmes was reflected in the present study 
which was carried out with female undergraduate students 
studying in Pokhara valley, Nepal. The result of the present 
study reveals that most of the students were aware HPV and 
Pap smear test (71.2%) which is shown in Table 4. Similar 
findings have been reported in the Middle East on levels of 
knowledge and awareness of the Pap smear test [42, 43], 
whilst women in Brazil had poor knowledge about HPV 
(70.9%) and also the Pap smear test (53.0%) [44]. The result 
of the present study is contrary to the study by Johnson et al. 
who reported that only 15.4% women in a village in Nepal 
heard about HPV [45]. It indicates the importance of women 
education and HPV awareness programmes in Nepal should 
reach village level for a better understanding of public health 
related diseases. When comparing health science students with 
non-health science students in the present study, we observed 
that health science students were more aware (98.8%) of HPV 
than non-health science students (47.5%). On considering 
knowledge about vaccine and willingness for vaccination, it is 
surprising that only 51.8% knew about HPV vaccine and were 
willing to be vaccinated. Only health science students (98.8%) 
showed their willingness for vaccination when compared with 
non-health science students (9.9%). It is discordant with the 
existing literature on HPV vaccine knowledge and 
acceptability in both high and low-income settings, which is 
that while levels of knowledge are generally low, individuals 
are still willing to receive vaccination against HPV [46-52]. 
Similarly on considering knowledge related to the risk, 
transmission, and measures to control of HPV, again health 
science students significantly differ (P <0.0001) from non-
health science students. It shows that health science students 
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have some benefit of health science teaching on an 
understanding of health related diseases like HPV.  
Religion  
Since Hinduism is the major religion of Nepal (86.51%), most 
of the students in this study were Hindus (74%). Most of them 
were aware of HPV and Pap smear test (75%) and were 
showed their willingness for HPV vaccination (55.6%) when 
compared with other religious students. In contrary to the 
present study, Joy et al. had reported in his study that more 
Christians were aware of HPV than other religions, which was 
conducted in 2011 in medical and allied-health professional 
schools in Pokhara [29]. In the present study, students belong 
to Christians, Muslims and Buddhist religion were aware of 
HPV, but not willing to get a HPV vaccination, particularly 
Muslim students (p<0.001). Religious beliefs play an 
important role in determining for vaccination. As reported by 
Guimond, in the Muslim culture, modesty is associated with 
religious beliefs and practices. Lack of sensitivity to modesty 
is a barrier for Muslim women to obtain cervical cancer 
screening and prevention [53]. However, it is difficult to 
decide the influence of religious beliefs on making a decision 
about vaccination by just interviewing students in the present 
study.  A study by Pelucchi et al. reported that more mothers 
than fathers were aware of HPV infection and favorable 
towards vaccinating their children against HPV [54]. A recent 
study in adolescent girls among a mixed population of Hindu, 
Muslim and Christian parents in India by Madhivanan et al. 
had reported that 71% of parents were showed their 
willingness to accept HPV vaccine for their daughters [55]. 
However, as cited by Marlow et al. “parents with strong 
religious or cultural views were less likely to accept HPV 
vaccination” [56]. Therefore population-based studies, 
including student’s parents, are necessary to know about 
parents and students willingness for HPV vaccination. 
Students from all other religions had poor knowledge related 
to the link between HPV and (a) risk; (b) transmission; and (c) 
measures to control, when compared to some studies from 
other parts of the world [35, 57-61]. 
Caste 
In the present study, on considering knowledge and attitudes 
of students towards HPV against caste system, students from 
all different castes were aware of HPV and Pap smear test. But 
only 52% of Brahmin, 61.2% of Newari, 61.1% of Dalit and 
50% of Chettri caste students showed their willingness for 
vaccination. While considering knowledge about the link 
between HPV and (a) risk; (b) transmission; and (c) measures 
to control, most of them had poor knowledge about it. Though 
Dalit girls are still getting less access to education, health care, 
and other opportunities than other higher castes groups in 
Nepal, implementation of scholarship programme made Dalit 
students to access education in schools [34]. This is very well 
reflected in our study with more number of Dalit students 
(22%) next to Chettri (26.3%) students studying in medical 
and non-medical schools. Considering their knowledge about 
HPV among Dalit students, a higher number of students were 
aware of HPV (82.1%), willing to be vaccinated (61.6%) and 
slightly more students knew about the transmission of HPV 
through multiple sex partners (51.7%).  Religious beliefs and 
attitude towards health and diseases have been changing 
nowadays. Sex is no longer a social taboo among many ethnic 
groups [62]. But this promiscuity had led more chances of 
spread of sexually transmitted diseases like HPV especially 
among Dalit caste [34]. A community-based health education 
programme should be implemented in Nepal to increase 
awareness and risk factors associated with HPV. Our study 
supports previous work showing that it is very important to 
educate people in Nepal about the transmission of HPV and 
the associated risk factors, [63, 64] and the benefits of HPV 
vaccine. Educating people about HPV and its vaccination will 
elevate public trust, which is a critical component of 
successful implementation of widespread vaccine coverage. 
There are several examples which proved that awareness 
programme about HPV and its vaccination in countries like 
Japan, India and Rwanda [39-41, 65-67] have increased public 
trust in HPV vaccine.  
 
Conclusion 
Our study outcome highlights the need for culturally salient 
HPV education among the Nepalese population. Education, 
religious beliefs, and caste can significantly influence in 
gaining knowledge about HPV which is reflected in the 
present study. A significant difference in knowledge and 
attitude towards HPV vaccination among different religious 
and ethnic groups are the interesting findings of this study. 
This study may give an insight to the Ministry of Health & 
Population and (international) non-governmental organizations 
working on the implementation of HPV vaccination in Nepal. 
Though women education and their participation in all sectors 
are increasing in Nepal, the social customs can place women at 
an increased risk of contracting human papillomavirus (HPV) 
[5]. Strong recommendations from health workers could 
influence the women in deciding to get vaccinated. The 
professionals should also be educated and trained about HPV 
vaccination, and its relation with cervical cancer to increase 
awareness and knowledge about HPV to women [68]. 
However detailed studies including both male and female 
students and their parents in different parts of the Nepal are 
essential to bring HPV awareness, implement of a vaccine 
against HPV and to eliminate the risk of HPV. 
 
Strength and limitations of the study 
Our study is one of the first of its kind in Nepal with large 
sample size, which is allowed us for comparisons between 
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important social characteristics such as religion and caste, is 
the key strength of this study.  It identifies the barriers to HPV 
vaccination with respect to religious beliefs and practicing 
caste system. But parents are not included in this study who 
are the deciding authority of students for vaccination, which is 
one of the limitations in this study. Though this study was 
conducted in Pokhara, Nepal, which might not reflect the 
levels of knowledge about HPV in other parts of the Nepal, 
this study may be helpful and taken as reference for studies 
and HPV vaccination programme in future.  One of the 
questions appeared as double question ‘Do you know about 
HPV vaccine and are you willing to be vaccinated?’  We can 
never know about the people who would have said ‘yes’ to 
having heard about HPV vaccine and ‘no’ about being willing 
to be vaccinated and vice versa.  
Future scope of the study:  
A multi-stage government funded large sample national based 
study should be carried out to find out the actual scenario in 
Nepal. 
What is already known on this topic: 
Few studies have been conducted in different parts of the 
Nepal showing that knowledge and awareness of HPV, 
cervical cancer and HPV vaccine among the Nepali women. 
What this study adds: 
This study reveals the association between religion and caste 
on the one hand and on the other knowledge and awareness of 
HPV, cervical cancer and HPV vaccine among the Nepali 
women. 
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